Results 171 to 180 of about 9,174,709 (287)

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease: Is the Field Ready for Precision Prescribing? [PDF]

J Pers Med
Jaja C, Sop DM, Campbell A, Smith WR.
europepmc   +1 more source

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US

Transfusion, EarlyView.
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega, Elisabet Viayna, Jiani Zhou, Susan L. Stramer   +3 more
wiley   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; July 2022

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Public perspectives on potential changes to malaria deferral criteria in Canada

Vox Sanguinis, EarlyView.
Abstract Background and Objectives As blood collection agencies (BCAs) seek to increase donor diversity, making changes to eligibility criteria to enable more people to donate is an important consideration. BCAs in Canada have a permanent deferral from whole blood and platelet donation for anyone with a history of malaria, a barrier to donation for ...
Courtney Joshua, Carmen Charlton, Joelle Kasongo, Biba Tinga, Jennie Haw   +4 more
wiley   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; November 2022

Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Uncovering the impact of the cardiovascular system on cerebrovascular health using MRI

Experimental Physiology, EarlyView.
Abstract Human cerebrovasculature is finely tuned to enable local changes in blood flow to meet the brain's demands, whilst protecting the brain from systemic changes in blood pressure, both acutely during a heartbeat and chronically over time. This review summarises cerebrovascular structure and function, their role in disease and neurodegeneration ...
Ian D. Driver, Kevin Murphy
wiley   +1 more source

Evaluation of hydroxyurea effect in patients with sickle cell disease: A prospective observational study. [PDF]

Indian J Pharmacol
Battina A, Gajbhiye S, Chindhalore C, Dakhale GN, Bhoyar A, Dube A, Kumbhalkar S, Khushoo V, Juneja R.   +8 more
europepmc   +1 more source

Cerebrovascular flow‐mediated dilation in humans: Methodological challenges, physiological interpretation and future integrations

Experimental Physiology, EarlyView.
Abstract Arterial shear‐mediated vasodilation is a well‐established measure of endothelial function and serves as a critical biomarker for cardiovascular disease risk. Endothelial function can be measured using a variety of experimental methodologies; however, the most widely adopted technique is ultrasound‐based flow‐mediated dilation (FMD), in which ...
Yi Zhen Bao, Tabitha V. Craig, Jenna C. McCrone, Kurt J. Smith, Michael M. Tymko   +4 more
wiley   +1 more source

Blood Transfusion and ABO Blood Groups in Sickle Cell Disease. [PDF]

Medicina (Kaunas)
Alsalman M, AlSahlawi M, Abid N, Elzorkany K, Abdallah E, AlQuraini A, Alkhalifa HA, Shafey M, Alsalman Z.   +8 more
europepmc   +1 more source

Five Steps to Safer Blood Transfusions if You Have Sickle Cell Disease

If you have sickle cell disease (SCD), you may need one or more blood transfusions (healthy blood from a donor put into your body) during your lifetime. During a blood transfusion, your blood and the donated blood must have matching antigens, or special ...

core